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Abstract 
Staphylococcus aureus ~/-hemolysins (HIgA, HlgB and HIgC) and Panton-Valentine leucocidins (LukS-PV and LukF-PV) 
are bi-component toxins forming a protein family with some relationship to c~-toxin. Active toxins are couples formed by 
taking one protein from each of the two subfamilies of the S-components (LukS-PV, HlgA and HlgC) and the F-components 
(LukF-PV and HlgB). We compared the mode of action of the six possible couples on leukocytes, red blood cells and model 
lipid membranes. All couples were leucotoxic on human monocytes, whereas only four couples (HlgA+HlgB, HIgC+HlgB, 
LukS-PV+HlgB and HlgA+LukF-PV) were hemolytic. Toxins HlgA+HlgB and HIgC+HlgB were also able to induce 
permeabilisation f model membranes by forming pores via oligomerisation. The presence of membrane-bound aggregates, 
the smallest and most abundant of which had molecular weight and properties imilar to that formed by a-toxin, was 
detected by SDS-PAGE. By infrared spectroscopy in the attenuated total reflection configuration (FTIR-ATR), the 
secondary structure of both components and of the aggregate were determined to be predominantly l]-sheet and turn with 
small variations among different toxins. Polarisation experiments indicated that the structure of the membrane complex was 
compatible with the formation of a 13-barrel oriented perpendicularly to the plane of the membrane, similar to that of porins. 
The couple LukS-PV+LukF-PV was leucotoxic, but not hemolytic. When challenged against model membranes it was able to 
bind to the lipid vesicles and to form the aggregate with the 13-barrel structure, but not to increase calcein permeability. Thus, 
the pore-forming effect correlated with the hemolytic, but not with the complete l ucotoxic activity of these toxins, suggesting 
that other mechanisms, like the interaction with endogenous cell proteins, might also play a role in their pathogenic 
action. © 1998 Elsevier Science B.V. All rights reserved. 
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I. Introduction 
Staphylococcus aureus produces everal toxic pore- 
forming compounds involved in a number of pathol- 
ogies of humans and cattle, of which m-toxin and 
~-lysin are perhaps the best characterised [1]. Among 
these toxins, leucocidins and y-hemolysins share the 
peculiarity of being bi-component. They are consti- 
tuted by two proteins that after being synthesised 
and secreted separately, as totally inactive compo- 
nents, act synergically to efficiently damage some 
mammalian cells. Since the discovery of leucocidins 
by Panton et al. in 1932 [2], the number of bi-com- 
ponent toxins belonging to this group has grown 
constantly and at least 11 members are known to 
date [3]. With the availability of their primary se- 
quence, it became vident hat staphylococcal leuco- 
cidins and y-hemolysins were actually forming a sin- 
gle family and were also related to a-toxin [4,5]. 
LukS-PV, HIgA and HlgC present around 63-75% 
of sequence identity among them, and slightly lower 
when compared with LukF-PV or HlgB. On the 
other hand, LukF-PV and HlgB are around 70% 
identical. Consequently, this family of proteins is div- 
ided into two sub-families: the class S components, 
which include LukS-PV, HlgA and HlgC, and the 
class F components, including LukF-PV and HlgB. 
Synergically active couples always include one S com- 
ponent plus one F component. Interestingly, m-toxin 
has around 26-30% of sequence identity with class F 
components and 20-25% with class S components. 
The mode of action of the Panton-Valentine leu- 
cocidin (PVL) has been reasonably well established. 
It was demonstrated that binding of the two compo- 
nents to the cell has a sequential character, so that 
the initial binding of the S component allows the 
subsequent binding of the F component on rabbit 
red blood cells (RRBC) and human polymorpho- 
nucleated cells [6,7]. However, for the couple 
HlgA+HlgB acting on human red blood cells 
(HRBC), a reverse binding sequence was reported 
[8,9]. The leucotoxic activity of PVL seems to be 
mediated by the opening of pores in the target mem- 
brane, whose formation involves toxin oligomerisa- 
tion [10,11]. A hexamer has been recently described 
[12], although a trimer was also reported earlier [8]. 
The permeability of the pore depends on the con- 
centration of divalent cations in the extracellular me- 
dium [7]. With concentrations of calcium lower than 
1 mM, the induced lesions are big enough to allow 
the leakage of intraceUular components which even- 
tually causes cell death by osmotic shock. In the 
presence of concentrations of calcium higher than 
1 mM, the lesions induced by PVL are essentially 
ion-sized pores, permeable to different divalent cati- 
ons. An influx of calcium induces intracellular 
events, such as degranulation, secretion, activation 
of phospholipase A2, release of leukotriene B4 with 
subsequent inflammation processes and chemotaxis 
of neutrophils and eosinophils, as well as DNA frag- 
mentation [7,11,13,14]. 
Since the V8 strain (ATCC 49775) produces both 
PVL and y-hemolysins [15], the possibility to find 
leucotoxic or hemolytic activity in mixed couples 
containing one leucocidin protein plus one y-hemo- 
lysin protein was open. Indeed, it was found that the 
mixed couple HlgA+LukF-PV presented both toxic 
activities, whereas the couples HlgC+LukF-PV and 
LukS-PV+HlgB presented only leucotoxic properties 
[15]. It was inferred that the S component is respon- 
sible for the selectivity of the couple, concluding that 
HlgA and HlgC are able to bind to both red and 
white cells, whereas LukS-PV derived couples can 
attack only white cells. 
Despite the relative abundance of data on the ac- 
tivity of these toxins on sensitive cells, up to now no 
study was reported on their action on model mem- 
branes. Here we present an investigation, performed 
with all the six possible couples formed by one S plus 
one F component, which compares the permeabilisa- 
tion of model membranes (lipid vesicles) with the 
leucotoxic and hemolytic activity and allows to better 
understand their mechanism of action. The use of 
this simple model system demonstrated the presence 
of a hexameric form inserted into the membrane, 
which appears to constitute the species out of which 
the pore is formed. The stoichiometry of the two 
components of the couple in the oligomer was deter- 
mined as well as the secondary structure of every 
single component and of the membrane bound 
oligomer. 
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2. Materials and methods 
2.1. Chemicals 
Lipids used were phosphatidylcholine (PC), pur- 
chased by Avanti Polar Lipids, and cholesterol 
(Cho) by Fluka, both more than 99% pure by 
TLC. Calcein, EDTA, Sephadex, Dulbecco's me- 
dium (PBS) and RPMI 1640 medium were from Sig- 
ma, SDS and Lubrol from Pierce, Triton X-100 from 
Merck, and alamar Blue from Alamar Bio-Sciences. 
The preparation and purification of single leucotoxin 
components has been described earlier [15,16]. 
Lyophilised o~-toxin was kindly supplied by Dr. Hun- 
gerer (Behring, Marburg, Germany), and used with- 
out further purification. 
2.2. Determination f the hemolytic activity 
Rabbit red blood cells (RRBC) were prepared 
from fresh venous blood collected in 6 mM EDTA, 
and washed thrice (10 min centrifugation at 700 x g, 
room temperature) in 30 mM Tris-HC1, 100 mM 
NaC1, 1 mM EDTA, pH 7.0 (hereafter buffer A). 
Human red blood cells (HRBC) from healthy volun- 
teers, were prepared similarly. 
2.2.1. Kinetic experiments 
The time course of hemolysis was followed photo- 
metrically at 650 nm, in a 96-well microplate, as 
described earlier [17]. In each well, the couple of 
proteins was added (both components at the same 
molar concentration if not otherwise stated) in a final 
volume of 100 ~tl of buffer A. Toxins were two-fold 
serially diluted and the reaction was started by add- 
ing 100 ~tl of RRBC (or HRBC), at a final concen- 
tration of 0.13% (v/v), which corresponds to an ini- 
tial A650 value of 0.1. The microplate was stirred and 
read every 8 s for 45 min. The extent of hemolysis 
was calculated as follows: 
% hemolysis -- 100(Ai--Ar)/(Ai--Aw) (1) 
where Ai and Af are the absorbances at the beginning 
and at the end of the reaction, and Aw that obtained 
after hypotonical lysis with pure water. The maximal 
rate of hemolysis (Vmax) was calculated, as the largest 
slope in the absorbance vs. time curve. 
2.2.2. Endpoint experiments 
Toxins were incubated with 0.13% RRBC (v/v), in 
500 ~tl of buffer A for 15 rain at 37°C (unless speci- 
fied differently). Thereafter, intact cells were pelleted 
(15 800×g, 3 min), and the released hemoglobin was 
measured by the absorbance at 415 nm. The extent 
of hemolysis was calculated as follows: 
% hemolysis = 100(A+-A_) / (Aw-A-)  (2) 
where A+ and A_ are the absorbances of the sample 
with and without toxin, and Aw is defined as above. 
Binding sequence assays were performed as two con- 
secutive end-point measurements, by adding to the 
same cells one single component at each step. An 
end-point assay was also used to study the temper- 
ature dependence of the permeabilising activity. Sam- 
ples containing both leucotoxin components were in 
this case incubated at different temperatures, and 
thereafter t eated at 0°C. 
2.3. Determination f the leucotoxic activity 
In vitro cytotoxic activity was studied on different 
human leukocytes: freshly isolated human mono- 
cytes, THP-1 cells (ATCC TIB 202, leukemic mono- 
cytes from a human newborn) and Raji cells (ATCC 
CCL 86, lymphocytes from human Burkitt lympho- 
ma) both obtained from the American Type Culture 
Collection (Bethesda, MA, USA). To monitor cell 
growth we used a photometric assay based on the 
alamar Blue reagent [18]. The reduction of this dye 
by living cells can be detected by measuring the dif- 
ference in absorbance at 575 nm and 608 nm 
(A575-A608). The assay was performed in a 96-well 
microplate. Along each line, toxins were two-fold 
diluted and incubated with 1 x 105 cells and 2.5% 
(v/v) alamar Blue, in RPMI-1640 medium without 
phenol red. The final volume in each well was 
200 ~tl. The microplate was maintained at 37°C, 
under a humidified 5% CO2 atmosphere, and read 
every 30 min, for a total of 30 h, in a microplate 
reader (UVmax from Molecular Devices). 
2.3.1. Preparation of monocytes from blood 
Blood was collected in heparin (1000 U/ml), di- 
luted in Dulbecco's phosphate buffered saline me- 
dium, and fractionated by centrifugation (400Xg, 
for 30 min), on 33% Ficoll (v/v). The band of mono- 
M. Ferreras et al. I Biochimica et Biophysica Acta 1414 (1998) 108-126 111 
cytes plus lymphocytes was carefully collected and 
washed twice in RPMI-1640 (280Xg, 10 min). Cells 
were placed in a 96-well microplate, 1.2x 105 cells 
per well, and allowed to adhere for 1 h. Non-adher- 
ent lymphocytes were carefully washed out while 
monocytes, attached to the bottom of the wells, 
were incubated overnight in a medium containing 
8.76% RPM1 1640 (v/v) supplemented with 2% glu- 
tamine, 0.4% gentamicin and 10% FCS (37°C, 5% 
CO2), and used for the cytotoxicity assay. Other 
cell lines were maintained in the same supplemented 
RPMI-1640 medium (37°C, 5% CO2) until assayed. 
2.4. Permeabilisation of lipid vesicles 
Small unilamellar vesicles (SUV) comprised of PC/ 
Cho at different ratios were prepared by sonication 
of multilameUar liposomes (2 mg of total lipid/ml of 
suspension) for 1 h, in a solution containing 80 mM 
calcein (from Sigma), neutralised with NaOH. Tita- 
nium particles released by the sonotrode were elimi- 
nated by centrifugation. The untrapped ye was re- 
moved by washing on Sephadex G-50, with buffer A. 
The permeabilising activity of toxins on SUV was 
evaluated by measuring the release of calcein [19]. 
Aliquots of washed SUV were placed in a 1-cm 
stirred plastic cuvette, in a total volume of 1.2 ml 
of buffer A. The final lipid concentration was 20 ~tg/ 
ml, unless otherwise stated. After adding the two 
components of the couple, always at the same con- 
centration, the time-course of calcein release was re- 
corded by the increase in the fluorescence emitted at 
520 nm (excitation at 494 nm), because of the de- 
quenching of the released ye which dilutes in the 
external medium. Toxin induced permeabilisation 
was calculated as: 
P(%) --- 100(Ft-F i ) / (Fm-Fi)  (3) 
where Fi is the initial fluorescence before adding the 
toxins, Ft the value at time t, and Fm the maximal 
value after addition of 1 mM Triton X-100. Sponta- 
neous release of calcein was negligible. 
2.5. Theoretical model for the interpretation of SUV 
permeabilisation 
The release data were analysed in terms of a stat- 
istical model that we have thoroughly described re- 
cently [20]. It was derived from that originally pre- 
sented by Parente et al. [21] and later improved by 
Rapaport et al. [22]. For the sake of clarity, we sum- 
marise here the main assumptions and the basic 
equations on which it relies. 
The process of permeabilisation is divided in two 
steps: partitioning of toxin monomers into the lipid 
bilayer (assumed to be very fast), and aggregation of 
membrane-inserted monomers (assumed to be rate 
limiting). When an aggregate has reached a critical 
size, comprising M monomers, a conducting unit is 
formed and internal calcein is quickly released. The 
fate of the oligomer after this step does not influence 
the release process any more, since the vesicle is al- 
ready empty. For example it can enter an irreversible 
state, as in the case of m-toxin, and this would not 
affect the treatment. The equilibrium constant of the 
incorporation process is given by: 
Tb 
Kl -- (To-Tb)'L (4) 
where To and L are the total concentration of toxin 
and lipid respectively and Tb is the concentration of
bound toxin. The aggregation process is instead 
characterised by c, the forward rate constant, and 
d, the backward rate constant. For simplicity they 
are assumed to be independent of the component 
that adds to the oligomer and of the degree of ag- 
gregation. The equilibrium constant is in this case: 
c 
x2 = (5) 
The percentage of calcein release is given by: 
N 
P(%) = IOOZAi'Z(M,t,i, K2, c ) 
i=M 
(6) 
where Ai is the fraction of vesicles with i monomers 
bound, N is the maximum number of toxin molecules 
that can be bound to one vesicle, and Z(M,t,i, K2,c) is 
the probability that a vesicle containing i bound 
monomers will also have an aggregate of order not 
smaller than M at time r 
Resulting from the fast partitioning step, Ai is time 
independent. Its expression can be derived from a 
binomial distribution [20,21]. All of the time depend- 
ence is contained in the probability factor Z, that can 
be expressed as [22]: 
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Z(M,t,i,  K2,e) =p( t )~- l (M- (M + 1)'p(t)) (7) 
where 
p(t) = 
K + Kv/-KT~-l coth(c.i.tff-K-YZT) 
and 
(8) 
1 
K = 1 + 2 ~/kAi'7-" (9) 
2.6. Preparation of toxin oligomers on SUV 
PC/Cho SUV (1:1 molar ratio) were prepared by 
sonication of a 6 mg/ml suspension of the lipids in a 
buffer containing 10 mM HEPES at pH 7.0 (buffer 
B). Aliquots of these vesicles were diluted to a 3 mM 
lipid concentration, and incubated with 7.5 ~tM of 
each component of the toxin couple in 200 ~tl of 
buffer B (final molar ratio lipid/toxin 200:1). After 
incubation at 37°C for 1 h, free toxins were washed 
out by ultrafiltration through polysulfone filters of 
300 kDa cut-off (NMWL, Millipore) using 2000 ×g 
for 20 min. The filtrates were tested for the presence 
of free toxins by measuring the hemolytic activity on 
RRBC. The washing process was repeated several 
times, adding 200 ~tl of buffer B each time, until there 
was no more hemolytic activity eluting in the fil- 
trates. The presence of toxins in the filtrates was 
also tested at each step by SDS-PAGE. The reten- 
tates, consisting of permeabilised vesicles and bound 
toxin, were then collected in the same buffer, and 
subjected to SDS-PAGE and FTIR analysis. 
2. 7. SDS-electrophoresis 
Electrophoresis was performed under denaturing 
conditions [23] using precast polyacrylamide minigels 
(Pharmacia, Uppsala, Sweden), with density gra- 
dients ranging from 4 to 15% or from 10 to 15%. 
Protein samples were dissolved in a buffer containing 
2.5% SDS (w/v) and boiled for 5 min, unless other- 
wise specified. In the case of samples containing tox- 
ins incubated with lipid vesicles, the preparations 
were also supplemented with 0.1 mg/ml Lubrol 
(Pierce) to better solubilise the toxins from the mem- 
brane. Electrophoresis was run at 10°C in a buffer 
containing 0.5% SDS (w/v), in a semi-automatic hor- 
izontal apparatus (Phastsystem by Pharmacia). Gels 
were stained with Coomassie brilliant blue or silver 
stain. The amount of protein was quantitated in 
Coomassie-stained gels by bidimensional densitome- 
try, using a Phastlmage densitometer (Pharmacia), 
with a band-pass filter at 613 nm. 
2.8. Fourier-transform infrared spectroscopy 
FTIR spectra were collected in the attenuated total 
reflection (ATR) configuration [24-26] on a Bio-Rad 
FTS 185 spectrometer quipped with a DTGS detec- 
tor with CsI window, a KBr beamsplitter and an 
ATR attachment by Specac. The instrument was 
constantly purged with dry air. Depending on the 
intensity of the signal, 64-256 interferograms were 
collected, Fourier transformed and averaged. Ab- 
sorption spectra in the region between 4000 and 
1000 cm -l, at a resolution of one data point every 
0.25 cm -l, were obtained using a clean ATR crystal 
as the background. For the study of single leucotoxin 
components, or their bi-component combination, 
40 ~tl of a solution containing approximately 1 mg/ 
ml of protein extensively dialysed against three 
changes of buffer B, were deposited and dried in a 
thin layer on one side of a 10-reflections Ge crystal 
(45 ° cut). For the lipid-bound toxin, 40 ~tl of the 
toxin-treated and extensively washed SUV prepara- 
tion described above, were spread similarly. For con- 
trol experiments oxin-free SUV were also applied in 
the same way. The crystal was housed in a liquid cell 
and flushed with D20-saturated nitrogen for 45 min 
before collecting the reported spectra. Spectra were 
also collected uring the deuteration process to verify 
that a steady state was attained [27]. 
The ATR-FTIR spectra were processed using 
Bio-Rad Win-Ir software package. They were cor- 
rected by subtracting the absorbance of residual 
H20 (to give a smooth baseline between 2000 and 
1700 cm-l), and a linear baseline between 1720 and 
1500 cm -1 . At this point, the amide I' band, between 
1700 and 1600 cm -1, was curve-fitted with a sum of 
Lorentzians using the Levenberg-Marquardt method, 
with no constrained parameter. The starting param- 
eters, i.e. the initial number, position, amplitude and 
width of the Lorentzians, was derived from the anal- 
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ysis of the deconvoluted spectrum [24,26]. The rela- 
tive content of secondary structure elements was 
eventually estimated by the areas of the individual 
peaks, assigned to a particular secondary structure 
in the standard way [24,28], and normalised by divid- 
ing by the area of the whole amide I' band. The 
small components around 1610 cm -l,  resulting 
from the contribution of side chains [29], were ex- 
cluded from the analysis. In the case of lipid-bound 
toxin, spectra were first corrected by subtracting the 
contribution of the lipid alone (minimising the signal 
of the phospholipid carboxyl groups at 1738 cm-1), 
and then analysed as above, or, alternatively, used to 
produce a differential spectrum by subtracting the 
spectrum of the pure bi-component couple, weighted 
by the area of the amide I' band. 
2.9. Quantitative analys& of the polarised A TR-IR 
spectra 
In the case of the lipid-bound leucotoxin couples 
the orientation of the various structural elements was 
determined by polarisation experiments. A rotating 
wire-grid polariser from Specac was used and man- 
ually positioned with orientation either parallel (11) 
or perpendicular (±) to the plane of the internal 
reflections. The dichroic ratio was calculated as 
R=AjjIA±, where AIj and Al were the integrated 
absorption bands in the parallel and perpendicular 
configuration, respectively. From the dichroic ratio 
a form factor, S, was calculated as [25,30,31]: 
2 2 2 Ex-REy + E z 
S = 1/2(3 COS 2 o~-I)(EZ-RE~-2E 2) (10) 
where a is the angle between the long axis of the 
molecule under consideration and the transition mo- 
ment pertaining to the investigated vibration; Ex, Ey 
and Ez are the components of the electric field of the 
evanescent wave along the three directions (the z axis 
is chosen perpendicular to the plane of the crystal). 
The terms E2~, E~ and E 2 were calculated according 
to the expressions given by Harrick [30,31] for thick 
films [32] using the following values: refractive index 
of the Ge crystal 4, refractive index of the deposited 
layer 1.43, incidence angle 45 °. The expression above 
was used to calculate the order parameters for: (i) 
the lipid chains (SL), using the symmetric and asym- 
metric CH2 stretching, i.e. integrating the bands cen- 
tred at 2850 and 1918 cm -~, respectively, with 
~=90°;  (ii) the whole amide I' band (Samidel'), inte- 
grating between 1600 and 1700 cm -~, with ~=0 ° 
[33,34]; (iii) the I~ strands (S~), summing the Lorent- 
zian components pertaining to 131 and 132 structures 
and using ~ = 70 ° [34]. 
From the order parameter the average tilt angle 7 
of the molecular axis with respect o the z axis (i.e. 
the perpendicular to the plane of the membrane) can 
be calculated according to [31]: 
S -- 1(3 cos y - l ) .  (11) 
Az was also used to calculate the lipid to toxin 
ratio (L/T) using the following algorithm, according 
to [33,34]: 
f2980 
LIT = 0.208 -(nres-2) l--SamideF J2800 AI (vL)dv 
2 1 + SL/2 /-1690 
Jl6oo A ± (V.mideX')dv 
(12) 
where nres is the total number of residues in the cou- 
ple, SL and Samidei, have been defined above. 
Fig. 1. Titration of the four bi-component toxins having hemolytic activity on red blood cells. A: Extent of hemolysis of rabbit RBC, 
expressed as a percentage of that obtained by incubating with distilled water. Different symbols have been used for different couples, 
as indicated. Points are mean + S.D. of 3 independent experiments. Curves were best fit of the Hill equation providing the following 
coefficients: HIgA+HlgB, 3.2; HIgC+HlgB, 1.7; LukS-PV+HlgB, 1.5; HlgA+LukF-PV, 1.8. Inset: Similar experiments, but with hu- 
man RBC (the same symbols have been used). Only the couple HlgA+HlgB was active, with a Hill coefficient 2.9. All other couples 
were inactive, albeit only HlgC+HlgB is shown. B: Maximal rate of hemolysis (Vmax) calculated from the kinetic urves of hemolysis. 
Symbols and inset have the same meaning as in part A. Lines have no theoretical significance here. The S and F component were al- 
ways applied at the same, reported, concentration. The time course of hemolysis was followed turbidimetrically at 650 nm, and the fi- 
nal % of hemolysis and Vmax were calculated as described in Section 2. 
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3. Results 
3.1. Hemolyt ic  activity 
The hemolytic activity of the six bi-component 
leucotoxins formed by taking one S component 
plus one F component from the ~/-lysin and the 
PVL of strain ATCC 49775, was assayed on rabbit 
and human RBC, in terms of percentage and max- 
imal rate (Vmax) of hemolysis (Fig. 1). Four  couples 
(HlgA+HlgB, HlgC+HlgB, LukS-PV+HlgB and 
HlgA+LukF-PV) presented hemolytic activity 
against rabbit RBC, whereas only HlgA+HIgB was 
active on human erythrocytes (insets). The hemolytic 
activity of  the couple LukS-PV+HlgB was never re- 
ported before. The relative hemolytic efficiency of 
these toxins are reported in Table 1, by comparing 
the concentration of  protein needed to give 50% of 
the maximal hemolysis (C50%), and the upper limit of  
Vmax (Vlim). On RRBC,  HlgA+HIgB had the stron- 
gest hemolytic activity, followed by HIgC+HlgB, 
LukS-PV+HlgB and finally HlgA+LukF-PV.  As in- 
dicated by Vii m values, HlgA+HlgB also expresses 
the fastest kinetics, followed by the others in the 
same order as above. On HRBC,  the hemolytic ac- 
tivity of  HlgA+HlgB was only about 50% of that on 
RRBC. For  comparison, the hemolytic activity of 
m-toxin is also reported, under the same experimental 
conditions. 
The sequentiality of  binding to both rabbit and 
human RBC was studied for all the active couples 
(i.e. HlgA+HlgB, HlgC+HlgB, LukS-PV+HlgB and 
HlgA+LukF-PV on RRBC, and HlgA+HlgB on 
HRBC).  Erythrocytes were incubated consecutively 
with the two components in both possible orders. 
After addition of the first component, cells were 
washed thrice, to remove the unbound protein. In 
all cases, (including HlgA+HlgB on HRBC),  release 
after the first addition was nil and hemolysis finally 
ensued only if (and every time) the S component was 
applied first. The temperature dependence of the he- 
molytic activity on RRBC was next analysed. For  
HIgA+HIgB, HlgC+HlgB, and LukS-PV+HlgB, the 
activity increased progressively from 0°C to 37°C, 
whereas in the case of  HIgA+LukF-PV, the activity 
at 20°C was higher than either at 37°C or at 0°C. No 
significant hemolysis was observed when any of the 
four toxin couples was added at 0°C. However, he- 
molysis ensued immediately if the cells, washed at 
0°C, were brought to 37°C. This suggests that the 
two components can indeed bind irreversibly to the 
cell during the incubation at 0°C, although the pro- 
gress to the active lesion is only possible at normal 
temperature. 
Table 1 
Hemolytic and leucotoxic activity of the bi-component toxins and a-toxin 
S component HlgA H IgC LukS-PV HlgA HlgC LukS-PV ct-Toxin 
F component HlgB HIgB HlgB LukF-PV LukF-PV LukF-PV 
Hemolytic RRBC C50o/,, (ng/ml) 10 + 1 26 + 1 160 + 20 630 + 50 0 0 62 + 2 
activity Vlim (gOD/s) 540 + 6 102 + 3 36 + 2 38 +- 3 0 0 229 + 14 
HRBC Cs0'yo (ng/ml) 25 + 3 0 0 0 0 0 0 
V~im (gOD/s) 150 + 5 0 0 0 0 0 0 
Leucotoxic Mono- C50o/,, (ng/ml) 217+-27 14+2 14+-3 177+_20 14+_5 3+_1 44+_1 
activity cytes % Cell deathmax 84.8 + 3.5 54.3 +_ 1.6 54.0 +- 2.2 64.1 + 2.4 49.3 + 3.5 52.9 + 0.0 87.6 +_ 1.0 
THP1 C50o/,, (ng/ml) 39+2 0 0 155+10 0 0 480+_21 
% Cell deathmax 73.1 +_3.5 0 0 92.3+2.4 0 0 69.2+ 1.6 
RAJI C50o/,, (ng/ml) 150 +_ 25 0 0 820 + 55 0 0 9750 + 325 
% Cell deathmax 63.5 + 3.4 0 0 58.5 + 2.8 0 0 82.4 +- 5.2 
Hemolysis was estimated, on rabbit and human RBC, by Cs0v. and [/]im (upper limit of Vrnax), obtained as shown in Fig. 1. Leuco- 
toxic activity was tested on monocytes from human blood and on two stabilised cell lines: TPH1 and RAJI. Relative efficiency was 
evaluated by the maximal amount of cell death in percent, and by the concentration necessary to reach half that value (C50o/,,), both 
obtained as shown in Fig. 4. Data are average +S.D. of at least two different experiments; 0 means there was no activity. 
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are reported in Fig. 3, together with that of s-toxin,  
as a function of the concentration of  the single com- 
ponents. 
3.2. Leucotox ic  activity 
The leucotoxic activity of  all the possible couples 
was assayed. This was done on freshly isolated hu- 
man monocytes and on two cultured human cell 
lines: THP-1 (monocytes f rom a newborn), and 
RA J I  (Burkitt l ymphoma cells). Results with pr imary 
monocytes are reported in Fig. 4. An assay of  cell 
viability in the presence of  different amounts of  
H IgA+HIgB is shown in panel A, whereas the activ- 
ities of all the different toxins, as indicated by the 
percentage of  cell death after 10 h, are compared in 
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Fig. 2. Single component dose dependence of the hemolytic ac- 
tivity of ~/-hemolysins. Percent of hemolysis was determined as 
in Fig. 1 except hat one of the two components was held at 
the indicated, constant, concentration, while the other was var- 
ied. Results are exemplified by the couple HIgC+HlgB. Curves 
were best fit of the Hill equation. The Hill coefficients obtained 
were reported in Fig. 3. Experiments were performed on rabbit 
RBC. Reported is one single experiment of three that were per- 
formed with similar results. 
Finally, since these are bi -component toxins, we 
studied the dependence of  RRBC lysis on the con- 
centration of  each component  separately. The sig- 
moidal titration curves (Fig. 2) suggested a co-oper- 
ative behaviour, which could be compatible with an 
oligomerisation mechanism. The curves were fitted to 
the Hill equation, and the resulting Hill coefficients 
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Fig. 3. Co-operativity of bi-component toxins vs. the concentra- 
tion of one of the two single components. Different symbols 
have been used for different couples, as indicated. Hill coeffi- 
cients were obtained from experiments like those in Fig. 2. 
Couples tested included the 3 different S-components coupled 
to HlgB. In the upper panel is the co-operativity in the S-com- 
ponent, expressed by the Hill coefficient obtained by changing 
the concentration of the S-component alone for every reported 
concentration of HlgB. In the lower panel is the co-operativity 
in the F-component, calculated in the same way. Points are 
mean + S.D. of 2-3 experiments. Dotted lines have no theoreti- 
cal significance. The Hill coefficient obtained with s-toxin is 
also indicated. 
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Fig. 4. Titration of the leucotoxic effect of bi-component toxins 
on human monocytes. A: Metabolic activity of freshly prepared 
human monocytes exposed to different doses of HIgA+HlgB, 
was determined by the differential absorption A575-A608 of ala- 
mar Blue (see Section 2). The control curve (upper one) was 
used as an indicator of the activity of 100% living cells. B: Ex- 
tent of cell death after 10 h, obtained by comparison with the 
control. Different symbols have been used for different couples, 
as indicated. Curves were best fit of the Hill equation providing 
the following coefficients: HIgA+HlgB, 2.0; HlgC+HlgB, 2.9 
(omitted for clarity); LukS-PV+HlgB, 1.3; HlgA+LukF-PV, 
2.2; HIgC+LukF-PV, 1.2; LukS-PV+LukF-PV, 1.5. The S and 
F component were always applied at the same, indicated, con- 
centration. The Hill coefficient obtained with c~-toxin in a simi- 
lar experiment was 1.5. 
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panel B. The couple acting at the lowest concentra- 
tion was clearly LukS-PV+LukF-PV, however, 
HlgA+HlgB was able to kill the largest fraction of 
cells. The leucotoxic activity on different cell lines of 
the six couples plus a-toxin, as expressed by the 
fraction of cells that could be killed and the concen- 
tration needed for half maximal activity (C50%) are 
reported in Table 1. All these toxins presented leu- 
cotoxic activity on primary human monocytes, but 
surprisingly THP-1 cells, which are also a human 
monocytic line, were only sensitive to HlgA+HlgB, 
HlgA+LukF-PV and c~-toxin. The same was true for 
RAJI cells, which is, however, a lymphocytic line. 
3.3. Permeabilisation of lipid vesicles 
The ability of the six bi-component toxins to per- 
meabilise lipid vesicles comprised of PC/Cho in dif- 
ferent proportions was next analysed. Up to the 
Table 2 
Composition dependence of the permeabilising activity of y-hemolysins and c~-toxin on SUV 
HlgA+HlgB HlgC+HlgB tx-Toxin 
PC/Cho 1:0 % release 1.3 + 0.8 3.0 + 1.2 0.0 
Vo (min -1) 0.18 + 0.01 1.02 + 0.01 0.0 
4:1 % release 2.8+0.5 4.2+_0.7 1.4+-0.9 
Vo (min - l )  0.42 +- 0.02 3.42 +- 0.06 0.30 +- 0.05 
2:1 % release 5.1 +0.5 5.2_+ 1.2 7.9+-0.9 
Vo (min -t)  0.90 + 0.01 3.40 +- 0.02 0.60 + 0.03 
1 : 1 % release 53.3 +- 5.7 20.1 +- 1.2 80.8 +- 2.8 
Iio (min -1) 37.3+- 1.2 11.7+-0.6 37.6+-2.2 
SUV comprised of PC/Cho at the reported molar ratios were exposed to y-hemolysins and c~-toxin. The final concentration of any 
component was 3 I.tg/ml, that of lipid was 10 ~tg/ml. Permeabilisation is reported by the percentage of release, with respect o that ob- 
tained with 1 mM Triton X-100, and by V0, the initial slope of the fluorescence change (normalised by dividing by the fluorescence 
after the detergent). Data are the average +S.D. of at least two different experiments. 
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TIL 
maximum concentrat ion  tested (10 ~g/ml per compo-  
nent)  only H lgA+HlgB and H lgC+HlgB were able to 
induce the release of  calcein f rom the l iposomes. As 
with cx-toxin [35], permeabi l isat ion increased with the 
amount  of  cholesterol present in the SUV (Table 2), 
however, the sensitivity to the presence of  cholesterol 
was lower in the case of  y-lysins. Wi th  both  active 
Fig. 5. Permeabilising activity of HIgA+HIgB, on SUV com- 
prised of PC/Cho (1:1) in buffer A. Calcein release was deter- 
mined, at the steady state, as a function of the toxin/lipid ratio 
(T/L) and expressed as % of the maximal value obtained with 
Triton X-100. In the upper panel are experiments obtained at 
constant lipid concentration (3.75 ~M) and variable toxin con- 
centration (the components were equimolar and the value re- 
ported is the total). In the lower panel, toxin concentration was 
constant (0.18 ~M) and lipid was variable. T/L ratio and true 
concentrations are reported in the lower and upper scales of 
each panel. The solid line is a best fit of the model discussed in 
the text and the two dotted lines define the confidence limit for 
the parameter M (i.e. an integer epresenting the size of the oli- 
gomeric pore). M is 6 for the best fit and 7 and 5 for the upper 
and lower limit, respectively (as shown). In a similar way we 
obtained the best fit values and the confidence limits for the 
other two parameters of the model, i.e. the equilibrium con- 
stants for the partitioning from buffer to lipid, KI = (9 + 4)× 10 4 
M-l, and for the aggregation within the lipid phase, 
/(2 = 0.25 + 0.1. It should be emphasised that these are best fit 
values common to the two experimental protocols. Further- 
more, the confidence limits (here and below) included around 
90% of the points, thus corresponding to about twice the S.D. 
In the two insets are the time courses of the fluorescence in- 
crease due to calcein leakage, at the indicated toxin or lipid 
concentrations. The solid lines are the predictions of the model 
using the best fit values for the three parameters M, Kl and K2 
obtained from the steady-state values, and adjusting only the 
fourth free parameter, i.e. the forward rate for aggregation, c. 
We obtained c=(7+2)× 10 -4 s -l, and from this we calculated 
d, the backward rate for removing a monomer from the aggre- 
gate, as d=(2.8+ 1)× 10 -3 s i Once again, it should be noted 
that this are best fit values common between the two experi- 
ments• Other conditions are as above. With similar experiments 
we determined also all the constants relative to the interaction 
of HIgC+HlgB with the same kind of vesicles. We obtained: 
M=6_+l, K1=(9+4)×104 M l, K2=0.04+0.01, c=(3+2)× 
10 -4  S -1 and d=(7.5 + 5)× 10 -3 s -l, which were valid both for 
constant lipid concentration (3.75 ~tM) and for constant toxin 
concentration (0.3 ~tM). <___ 
couples, and  SUV conta in ing  equ imolar  amounts  of 
PC and cholesterol, we determined the dependence of 
calcein release on the concentrat ion  of both reactants 
separately (Fig. 5). The exper imental  data were ana-  
lysed in terms of  a model  that we have recently used 
[20]. It describes permeabi l isat ion as the result of  the 
format ion  of an ol igomeric toxin lesion on the 
vesicles. The steady state effects are accounted by 
three parameters only:  M, the min ima l  number  of 
monomers  necessary to form a lesion; K1, the parti-  
t ion coefficient of  the toxin between water and lipid 
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phase and/(2, the equilibrium constant for the ag- 
gregation of toxin monomers within the membrane. 
Numerical solutions were obtained by varying in- 
dependently these three parameters over a wide range 
of values and choosing those providing the best ~2 
values for further refinement. After a few iterations, 
we found the triplet giving the best fit for each cou- 
ple. The level of confidence on the three parameters 
was estimated by comparing the predictions of the 
model when the parameters were changed one at a 
time around the best value as shown in Fig. 5 for the 
case of the size M. We observed that the formation 
of a lesion of size M = 6 + 1 provided an adequate fit 
with both couples. Also the partitioning constant K~ 
was the same: (90 + 40) x 103 M -l . A significant dif- 
ference was observed instead in the case of the ag- 
gregation constant K2, which was 0.25+0.10 with 
HlgA+HlgB and 0.04 + 0.01 with HlgC+HlgB. This 
resulted in a lower tendency of HlgC+HlgB to ag- 
gregate on the surface of the SUV, with the overall 
effect that HlgA+HlgB permeabilised SUVs about 
10 times better than HlgC+HlgB. Analysis of the 
kinetics (insets in Fig. 5) allowed estimation of c, 
the forward rate constant for aggregation. We ob- 
tained c=(7+2)x10 -4 s -1 for HlgA+HlgB and 
(3 -I- 2) X 10 -4 s -! for HlgC+HIgB. 
3.4. Characterisation f the oligomers by SDS-PAGE 
The dose-dependence of the hemolytic, leucotoxic 
and permeabilising activities of bi-component toxins 
(Figs. 1-5) suggests the formation of oligomers on 
the lipid membrane. This is a common mechanism 
for bacterial toxins, including m-toxin, however, in 
the case of bi-component toxins it should be clarified 
whether both of the toxin components are present in 
the oligomer, and, in that case, with what stoichiom- 
etry. To answer this, we further studied the nature of 
the oligomers formed by HIgA+HlgB and 
HlgC+HlgB on lipid vesicles. The couple LukS- 
PV+LukF-PV, which has no permeabilising activity, 
was also included in order to identify at which step it 
was deficient. After incubation with SUV, unbound 
toxins were removed by ultrafiltration. The washes 
were checked for the presence of free toxins, by 
measuring their hemolytic activity and by SDS- 
PAGE. With all couples the content of free toxin 
in the filtrates was in monomeric form and had a 
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Fig. 6. Analysis of toxin oligomers on SUV. SUV preincubated 
with three bi-component toxins and or-toxin were washed 8 
times on polysulfone filters to get free of unbound toxin and 
then subjected to SDS-PAGE before (panel A) or after boiling 
(panel B). A: Lanes 1 and 6 were M.W. standards of the indi- 
cated weight; lanes 2-5 contained t~-toxin, LukS-PV+LukF-PV, 
HIgC+HIgB and HlgA+HlgB, respectively. Very small concen- 
trations of monomers were detected (higher in the case of 0t- 
toxin). A high M.W. band of around 200 kDa appeared with 
all samples. In the case of bi-component toxins additional 
bands of higher mass were also present. The M.W. observed 
were: 190, 320, 450 and 600 kDa. B: When the lipid induced 
oligomers were boiled (lanes S), all of the protein migrated in 
only two bands with apparent M.W. 31 and 35 kDa which cor- 
respond to the mass of the single monomeric omponents (theo- 
retically 32 and 34 kDa for the S- and F-component, respec- 
tively). The concentration of the two components was evaluated 
from the optical density of their band, by comparison with 
known amounts of the same component applied in lanes 1-5 
(these contained 40, 80, 120, 160 and 240 ~tg/ml of the F-com- 
ponent and 240, 160, 120, 80 and 40 I.tg/ml of the S-component, 
respectively). The evaluated concentrations are reported in the 
lower part of the panel. Gels were stained with silver in panel 
A and with Coomassie blue in panel B. 
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Fig. 7. Infrared-ATR spectra in the amide I' region of deuter- 
ated films of all S. aureus leucotoxins investigated as single 
components. One class S component (LukS-PV) and one class 
F component (LukF-PV) are shown as examples, together with 
(z-toxin. The spectrum (solid line), seven to eight Lorentzian 
component bands obtained by curve-fitting as explained in the 
Section 2 (thin solid lines), and their sum (dotted line) are 
shown in each case. Best fitted Lorentzian components were as- 
signed to a particular secondary structure in the usual way 
[24,28] and the assignments are indicated next to each band for 
the case of LukS-PV. We used the following criteria: bands in 
the regions 1696-1680 cm -1 and 1670-1660 cm -1, 13-turn (t); 
band at 1675+4 cm - j ,  antiparallel 13-sheet (131); band at 
1654+4 cm I, m-helix ((z); band at 1645+4 cm -t ,  random coil 
(r); bands in the region 1640-1620 cm -1, parallel plus antipar- 
allel 13-sheet (132). The minor bands around 1610 cm -I were at- 
tributed to side chains [29]. The evaluated secondary structures 
of all components are compared in Table 3. 
<-- 
peak between wash 2 and 4, thereafter declining to 
virtually nil at wash 8 (not shown). Eight washes 
were therefore used throughout. The retentates, con- 
taining SUV with bound toxins, were collected and 
subjected to SDS-PAGE, either with or without boil- 
ing. Unboiled samples appeared as high molecular 
weight proteins with no significant bands corre- 
sponding to the single components (Fig. 6A). A sim- 
ilar pattern was obtained with all three couples, 
although with HIgA+HlgB and HIgC+HlgB the 
bands were less intense. Despite an evident smearing, 
due in part to the interaction with the lipids, a few 
Table 3 
FTIR determination of the secondary structure of 
cotoxins, as single components, and c~-toxin 
S. aureus leu- 
Protein 131 13 2 t cx r 13tat 
HlgA 10 52 14 9 15 76 
HlgC 10 49 13 11 17 72 
LukS-PV 10 50 10 9 21 70 
HlgB 9 46 13 9 23 68 
LukF-PV 8 49 13 14 16 70 
(z-Toxin 6 39 16 12 27 61 
c~.Toxin b 131 +132 = 56 9 6 29 65 
The secondary structure elements were calculated as shown in 
Fig. 7. Errors of such determinations are typically +5%. The 
standard deviations derived from several independent fits were 
always smaller than this. 
a13to t = 13-structure total = 131 +132+t" 
bDetermined by X-ray crystallography of the DOC-induced 
oligomer [37]. 
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Fig. 8. Infrared-ATR spectra in the amide I' region of deuterated films of some bi-component toxins. The toxin couples were taken ei- 
ther from mixtures in solution (left panels) or as SUV-bound oligomers (right panels) prepared as shown in Fig. 6. The spectrum, the 
fitted Lorentzian components with their assignment and their sum are shown as in Fig. 7. HlgA+HlgB and LukS-PV+LukF-PV are in 
the upper and lower panels, respectively. HIgC+HIgB was also analysed in the same way (not shown). All the evaluated secondary 
structures are reported inTable 4. 
major bands could be identified, especially with 
LukS-PV+LukF-PV. They corresponded to molecu- 
lar species around 6, 10, 14 and 18 times larger than 
the average molecular weight of the single compo- 
nents (33 kDa). The most intense band was always 
that near 200 kDa, similar to the 0c-toxin oligomer. 
When the samples were boiled, no oligomeric form 
was left, and only the two bands corresponding to 
the single monomeric omponents appeared (Fig. 
6B), suggesting that this treatment splits the oligo- 
mers into the constituent monomers, as with t~-toxin. 
These samples could therefore be used to evaluate 
the stoichiometry of such oligomers. The amount 
of each component was separately determined by 
comparison with a calibration obtained including in 
the same gel known quantities of the monomer. In 
this way the ratio S/F component was evaluated to 
be 0.96+0.06, 0.89+0.06 and 1.11+0.08, for 
HIgA+HIgB, HlgC+HIgB and LukS-PV+LukF-PV, 
respectively. We could also calculate the true amount 
of toxin recovered, and, by comparison to the initial 
amount applied, the fraction of toxin that was bound 
to the membrane. It was found that =20% of 
HlgA+HlgB and HlgC+HIgB, and = 60% of LukS- 
PV+LukF-PV, were retained. If the incubations were 
performed in the absence of SUV, all of the protein 
came out in monomeric form in the filtrate at the 
first washes and nothing was retained (not shown). 
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Fig. 9. Polarised ATR spectra of the amide I' band of membrane bound bi-component toxins. The toxin oligomers analysed in the 
right panels of Fig. 8 were also investigated using linearly polarised light. Polarisation was either parallel (left panels) or perpendicular 
(right panels) to the plane of the internal reflections. The spectrum, the fitted Lorentzian components with their assignment and their 
sum are shown as in Figs. 7 and 8. HIgA+HIgB and LukS-PV+LukF-PV are in the upper and lower panels, respectively. HlgC+HlgB 
was also analysed in the same way, but not shown. The dichroic ratio R~=Af~ll/A~± ' (where 13 means ]31+~2) was 1.58+0.05, 
1.56 + 0.04 and 1.60 + 0.05 for HlgA+HlgB, HIgC+HIgB and LukS-PV+LukF-PV, respectively. 
3.5. Secondary structure of bi-component toxins by 
FTIR spectroscopy 
The secondary structure of all single components 
was estimated by ATR-FTIR spectroscopy, and 
compared to that of tx-toxin (see examples in Fig. 
7). Spectra were fitted to the sum of single Lorent- 
zian bands and these were attributed, according to 
the standard interpretation [28], to four secondary 
structures, i.e. IS-turn, m-helix, random coil and [3- 
sheet. The last is split in two bands, called 131 and 
13 2, that contain the contribution from antiparallel 
and from parallel+antiparallel [~-strands, respective- 
ly. Average compositions are reported in Table 3. 
It appears that all proteins in the family were mainly 
composed of p-structure. In particular, the spectra of 
the class-S components were very similar to each 
other, and had the highest content in ]3-structure of 
the group. Those of the class-F components were 
also very homogeneous, but slightly different from 
the previous. Finally, that of or-toxin was the most 
dissimilar, yet still closely related to that of the class- 
F components. This reflected well the phylogenetic 
subdivision inside this group of proteins [3,36]. The 
determined secondary structure of tx-toxin was com- 
pared to that derived from the crystallographic anal- 
ysis of the oligomer it forms in DOC [37] and found 
to be consistent. 
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To get some insight into the conformational 
changes that might accompany the formation of 
the pore we evaluated the secondary structure of 
the oligomers formed in SUV by the three couples 
previously analysed by SDS-PAGE, and compared it
either to that of the same couples in solution or to a 
simple average of the two single component struc- 
ture. Only minor changes were observed in the differ- 
ential spectra, i.e. an excess of absorbance in the 
1680-1660 cm -1 region in the case of HlgA+HlgB 
and HlgC+HlgB, but much less with LukS- 
PV+LukF-PV. This was consistent with a slight in- 
crease in [3-structure and decrease of cx-helix evi- 
denced for the ~,-lysins by curve fitting (Fig. 8 and 
Table 4). Spectra collected using light linearly polar- 
ised at 90 ° (Fig. 9) allowed to evaluate the L /T  ratio 
in each of the lipid-bound toxin samples (see Section 
2). L /T  values of 620 + 40, 580 + 40 and 310 + 20 were 
obtained for HlgA+HlgB, HlgC+HIgB and LukS- 
PV+LukF-PV, respectively. They compared nicely 
to the upper bounds of 1000, 1000 and 330 that 
could be evaluated for the same samples using the 
protein concentration measured by SDS-PAGE (Fig. 
6B) and assuming that all of the lipid was recovered 
by the ultrafiltration process. Finally, from polarisa- 
tion experiments, we could also evaluate the average 
Table 4 
Secondary structure of S. aureus bi-component toxins 
tion and in membrane-bound form 
in solu- 
Protein 1~1 [32 t cz r [3tot 
(HlgA+HlgB) a 9 50 14 9 19 72 
HlgA+HlgB b 7 50 13 12 18 70 
(HlgA+HlgB)~,es 12 49 17 4 18 78 
(HlgC+HlgB) 10 47 13 10 20 70 
HlgC+HlgB 11 46 13 8 22 70 
(HlgC+HlgB)ve~ 14 39 21 4 22 74 
(LukS+LukF) 9 50 12 11 18 71 
LukS+LukF 9 40 16 15 20 65 
(LukS+LukF)ves 16 39 8 14 23 63 
The secondary structure elements were calculated as shown in 
Fig. 8 and Table 3. 
~(S+F) is the averaged structure of the indicated S and F com- 
ponent, as taken from Table 3. 
bS+F is the structure of an equimolar mixture of the two com- 
ponents S and F in solution, obtained as shown in Fig. 8. 
~(S+F)ves is the structure of the oligomer formed by the two 
components S and F on lipid vesicles. 
orientation of the oligomers in the bilayer (Fig. 9). 
Using the same technique that was applied to porins 
[34], we estimated that the average angle formed by 
the [3-strands ([31+[32 bands) with the normal to the 
plane of the membrane, was 37 °+ 1 °, 36 °+ 1 ° and 
38 °+ 1 ° for HlgA+HlgB, HlgC+HlgB and LukS- 
PV+LukF-PV, respectively. 
4. Discussion 
All possible bi-component combinations between 
S. aureus PVLs and ),-hemolysins were analysed for 
activity on RBC, leukocytes, and model membranes. 
Couples involving HIgB presented hemolytic activity 
on RRBC (Fig. 1 and Table 1), including that with 
LukS-PV, a combination previously reported as non- 
hemolytic [15]. Conversely, LukF-PV was slightly he- 
molytic only in combination with HlgA. The sigmoid 
dose-dependence of the hemolytic activity of these bi- 
component toxins suggests that their action relies on 
the formation of an oligomer, as in the case of tx- 
toxin. With all the hemolytic ouples, and both on 
RRBC or HRBC, the S component was the first to 
bind to the membrane, whereas the F component 
was never able to bind to the cell if the S component 
was not present (Table 2). This is in agreement with 
most previous results [6,7], but contrasts to those 
reported by a group for the case of HIgA+HIgB on 
HRBC [8,9]. We do not have at present any reason- 
able explanation for this disagreement, however, we 
notice that our results provide a more consistent be- 
haviour for all the toxins within this family. 
The observed sequentiality suggests that the S 
component may bind to a receptor. To distinguish 
between the respective role of the S and F compo- 
nents, we studied their individual contribution to the 
co-operativity in hemolysis (Figs. 2 and 3). The co- 
operativity in the binding of the S component is low- 
er than that of the F component. In particular, 
LukS-PV presents negative co-operativity (Hill co- 
efficient, H, around 0.2), HlgC no co-operativity 
(H around 1), whereas HlgA is the only one with a 
positive co-operativity (H around 3). Apart from 
HlgA, these values are consistent with a non-co-op- 
erative (or even competitive) binding to a receptor, 
indicated also by the fact that the co-operativity of 
the S component does not depend on the concentra- 
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tion of the F component. The peculiarity of HlgA is 
probably due to the fact that, as we had previously 
demonstrated [16], it may also bind non-specifically 
to the cell membrane. The co-operativity with the F 
component (HlgB) is higher, and, except with HlgA, 
dependent on the concentration of the S component. 
The upper value of H is between 3 and 4 suggesting 
the formation of an oligomer comprising 3 or 4 HIgB 
monomers and requiring a sufficient amount of the S 
component for full development. 
The pore-forming action of m-toxin involves at 
least three consecutive steps: binding of monomers 
to the erythrocyte membrane; assembly of a non- 
lytic oligomer; reorganisation i to a functional ion 
channel [38--41]. It has been shown that the first step 
is temperature-independent, whereas the later events 
require temperature. We observed the same situation 
also for leucocidins and ~/-hemolysins. Both S and F 
components can bind to RBC membrane at 0°C, but 
are unable to generate a lytic lesion, unless the me- 
dium containing cells and bound toxins is warmed 
up. HlgA+LukF-PV, alone, presented an activity 
higher at 20°C than at 37°C, as observed earlier for 
or-toxin [42]. These facts suggest hat the mechanism 
of action of leucocidins and q(-hemolysins also in- 
volves several independent s eps, at least the binding 
of toxin monomers and a further structural reorgan- 
isation leading to the final pore. 
All the couples were leucotoxic on primary human 
monocytes (Fig. 4 and Table 1). Couples based on 
either LukS-PV or HlgC were active at low doses 
(LukS-PV+LukF-PV was the most active based on 
C50%), but were able to kill only around 50% of the 
cells, whereas couples containing HIgA required 
higher doses, but could kill almost all the cells. 
This suggests that LukS-PV and HIgC require a re- 
ceptor that is not present on all monocytes in the 
preparation, or on some other white cells that might 
remain in the culture. Interestingly, only couples 
based on HlgA were toxic for THP1 and RAJI cells, 
although TPH1 cells are also monocytes. Hill coeffi- 
cients for the leucotoxic activity were in the range 
1.2-2.9, confirming a positive co-operativity also 
for this effect. 
The activity in the absence of any specific receptor 
was investigated using SUV as a model membrane 
(Fig. 5). HIgA+HlgB and HlgC+HlgB (the y-hemo- 
lysins) indeed presented permeabilising activity, sim- 
ilar to that of t~-toxin, HIgA+HIgB being the most 
active. This confirmed that at least HlgA and HIgC 
could bind to the lipid membrane directly and coop- 
erate with HlgB (but not with LukF-PV) to form a 
pore. All couples with LukS-PV were inactive on 
SUV, at least at the concentrations tested. Statistic 
analysis of the permeabilising activity of the y-hemo- 
lysins (Fig. 5) suggested that the lesions were formed 
by hexamers. Such oligomers could be shown directly 
by SDS-PAGE, but unexpectedly, besides with 
HlgA+HlgB and HIgC+HIgB, they were also ob- 
served with LukS-PV+LukF-PV (Fig. 6A) in an 
even higher proportion. This indicates that LukS- 
PV and LukF-PV were also able to bind to the mem- 
brane and to assemble the oligomer, albeit not to 
permeabilise the vesicles. Thus, the defective step 
could be the lack of a conformational change of 
the preassembled oligomer into a calcein-permeant 
channel. Unlike the oligomer formed by t~-toxin in 
deoxycholate, which is a heptamer [37], the major 
oligomeric species appearing on the membrane of 
the liposomes was a hexamer. Furthermore, within 
experimental error, the stoichiometry of the two dif- 
ferent components in the oligomer was 1 : 1 (Fig. 6B), 
implying that both the S and F components were 
present in the same extent, which would not be pos- 
sible for a heptamer. This hexameric nature is not 
unexpected since: (i) oligomers of 7-1ysins observed 
by others on RBC were indeed found to be hexamers 
[12]; (ii) or-toxin itself apparently can form hexamers 
besides heptamers on phospholipid bilayers [41]. In- 
terestingly, with y-lysins incomplete rings, harbouring 
four subunits and attached to the complete hexam- 
ers, were also observed on RBC [12]. They could 
correspond to the forms comprising 10 and 14 mono- 
mers that we have seen in SDS-PAGE. 
Although sequence homology suggests that 7-1y- 
sins, PVL and or-toxin may have a similar secondary 
structure [36], the overall identity is always below 
30% and henceforth a direct experimental demon- 
stration of such similarity is required. We found by 
FTIR spectroscopy that indeed bi-component toxins 
have a secondary structure consisting prevalently of 
~-sheet and turn, similar to that of a-toxin. No ma- 
jor changes were observed upon formation of the 
membrane-bound oligomers with respect o an equi- 
molar mixture of the two components in water, or a 
simple mean of the two individual structures. Polar- 
M. Ferreras et al. / Biochimica et Biophysica Acta 1414 (1998) 108-126 125 
isation experiments indicated that the average orien- 
tation of the 13-strands in the oligomers is similar to 
that in the porins, which would also be compatible 
with the formation of an a-toxin like channel [37]. 
The oligomer formed by the PVL, despite having an 
overall structure and orientation similar to that of ~/- 
hemolysins, did not show a minor increase in 13 struc- 
ture and decrease in a structure that was apparent 
with those. Although one should be cautious about 
these differences because they are near to the resolu- 
tion limit of the technique, they would be compatible 
with a multistep mechanism of action similar to that 
of a-toxin: monomers bind to the membrane, they 
form an inactive oligomer which, in the case of ~/- 
hemolysins but not of leucocidins, experiences a fur- 
ther (small) conformational change to become a 
functional lesion in the form of a pore. These find- 
ings also suggest that the in vivo leucotoxic activity 
of LukS-PV+LukF-PV might involve a different 
mechanism, e.g. the interaction with endogenous 
cell proteins for pore formation that was shown re- 
cently, [14,43]. 
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